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INTRODUCTION
G proteins play important roles in cells as signal transducers 
that convert extracellular signals into intracellular signals. G 
proteins comprise alpha, beta, and gamma subunits (Gα, Gβ, 
and Gγ, respectively), which couple to seven-transmembrane 
domain receptors called G protein-coupled receptors (GP-
CRs). Activation of GPCRs induces the exchange of GDP with 
GTP in the Gα subunit, which leads to the activation of G pro-
teins and dissociation of the Gα subunit from the Gβγ sub-
unit.1 Gα proteins are grouped into four families: Gs, Gi, Gq, 
and G12. Among the four families, Gα12 was discovered last, 
and its roles in the modulation of cellular responses including 
proliferation, differentiation, and apoptosis have not been 
elucidated fully. Gα12 protein has been found to act as a po-
tent oncogene and to stimulate the invasiveness of human 
cancer cells.2,3
MicroRNAs (miRNAs), small noncoding RNAs, have been 
found to regulate the gene expression by posttranscriptional 
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regulation, which results in the silencing of target genes. As 
miRNAs are involved in the regulation of many cellular func-
tions, misregulated expression of miRNAs can lead to many 
diseases, including cancer and atherosclerosis.4,5 MicroR-
NA-155 (miR-155) is encoded from the processing of the B cell 
integration cluster gene and is known to be involved in onco-
genesis and immune responses. Recently, miR-155 has been 
also found to play a crucial role in the pathogenesis of athero-
sclerosis, including the migration of vascular smooth muscle 
cells (VSMCs), lipid uptake by macrophages, and inflamma-
tion in and apoptosis of endothelial cells.6 However, studies of 
the effects of miR-155 on atherosclerosis have produced con-
flicting results, and further study is needed to elucidate the 
role of miR-155 in atherosclerosis. 
Many studies have shown that the G protein-signaling sys-
tem can modulate the apoptosis of numerous cells;7 however, 
it is not known whether Gα12 signaling can regulate the apop-
tosis of vascular cells. Thus, we investigated whether Gα12 af-
fects apoptosis induced by serum deprivation in human um-
bilical vein endothelial cells (HUVECs). We found that Gα12 
protected HUVECs from serum withdrawal-induced apopto-
sis through the regulation of miR-155 expression. 
MATERIALS AND METHODS
Cell culture 
HUVECs were purchased from Invitrogen (Carlsbad, CA, USA) 
and were grown in endothelial growth medium-2 (EGM-2) 
supplemented with 2% fetal bovine serum and an EGM-2 Bul-
let Kit (Lonza, Walkersville, MD, USA). Cells were cultured in 
5% CO2 at 37°C in an incubator and were used between pas-
sages 4 and 7 in this study. 
Transfection 
Synthetic small-interfering RNA (siRNA), miR-155 mimic, or 
miR-155 inhibitor were transfected into cells using Lipo-
fectamine 2000 reagents according to the manufacturer’s 
guidelines (Invitrogen, Carlsbad, CA, USA). The following ma-
terials were used: siRNA targeting Gα12 (Thermo Scientific 
Dharmacon, Lafayette, CO, USA); control siRNA (Stealth siR-
NA duplex, Invitrogen, Carlsbad, CA, USA); miR-155 mimics 
(sense: 5’-CUCCUACAUAUUAGCAUUAACA-3’; antisense: 
5’-UGUUAAUGCUAAUAUGUAGGAG-3’, Genolution, Seoul, 
Korea); miRNA for negative control (sense: 5’-CCUCGUGCC 
GUUCCAUCAGGUAG-3’; antisense: 5’-CUACCUGAUGG 
AACGGACGAGG-3’); and miR-155 inhibitor, which com-
prised single-stranded RNA oligonucleotides conjugated with 
2’-O-methoxyethyl phosphorothioate (Genolution, Seoul, 
Korea). 
Immunoblotting 
Immunoblot analysis was performed as described previous-
ly.8 Cell lysates were subjected to SDS-PAGE, and the resultant 
blot was analyzed with specific antibodies: antibodies against 
Gα12 and β-actin, which were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA, USA), and antibodies against 
cleaved caspase-3 and phosphorylated p38 mitogen-activated 
protein kinase (MAPK) (Thr180/Tyr182), purchased from Cell 
Signaling Technology (Beverly, MA, USA). 
Detection of miRNA expression by quantitative RT-PCR
The expression of miRNA was analyzed by quantitative real-
time PCR (RT-PCR) as described previously.9 In HUVECs, 
miRNAs were isolated using the mirVana miRNA isolation kit 
(Ambion, Austin, TX, USA) according to the manufacturer’s 
instructions and were reverse transcribed with a TaqMan Mi-
croRNA reverse transcription kit (Applied Biosystems, Foster 
City, CA, USA) using miRNA sequence-specific primers for 
miR-17-3, miR-31, miR-155, and miR-191. Briefly, for the RT 
reactions, 30 ng of miRNA was used in each reaction (15 μL) 
and was mixed with the RT primer (3 μL). The RT reaction was 
performed at 16°C for 30 min, 42°C for 30 min, and 85°C for 5 
min. MiRNA levels were quantified via RT-PCR (StepOnePlus; 
Applied Biosystems) using TaqMan MicroRNA assays. The 
amplification steps included denaturation at 95°C, followed 
by 40 cycles of denaturation at 95°C for 15 s and then anneal-
ing at 60°C for 1 min. All reactions, including controls, were 
performed in triplicate. Relative expression of miRNAs was 
analyzed using the 2-ΔΔCt method and was normalized via 
RNU6B expression for all samples.
Terminal deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL) assay
HUVECs were seeded in the confocal dish, deprived of serum 
to induce apoptosis, and then fixed in 4% paraformaldehyde 
for the terminal deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL) assay according to the manufacturer’s in-
structions (Roche, Nutley, NJ, USA). Cells were counterstained 
with propidium iodide to visualize all of the nuclei. Stained 
cells were viewed under a fluorescence microscope (Carl Zeiss, 
Oberkochen, Germany). 
Data analysis 
At least three independent experiments were conducted for 
all analyses. Values are expressed as average and standard de-
viation. Student’s t-test was used to compare averaged values, 
and p-values of <0.05 were considered significant.
RESULTS 
Gα12 siRNA augments serum withdrawal-induced 
apoptosis of HUVECs
To examine the effects of serum withdrawal on HUVEC apop-
tosis, HUVECs were deprived of serum for the indicated times, 
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Fig. 1. Gα12 inhibits serum withdrawal-induced apoptosis of HUVECs. (A and B) Effect of serum deprivation on HUVEC apoptosis. HUVECs were de-
prived of serum for the indicated times, and apoptosis was assessed via immunoblot analysis with antibody to cleaved caspase-3 and a TUNEL as-
say. (C and D) Effect of Gα12 siRNA on serum withdrawal-induced apoptosis. HUVECs were transfected with Gα12 siRNA. These cells were cultured 
48 h after transfection in the serum-free condition for 6 h and were analyzed for apoptosis via immunoblotting with antibodies to cleaved caspase-3 
and phosphorylated p38 and the TUNEL assay. The blots are representative of at least three independent experiments, and the histograms show the 
average and standard deviation. *p<0.05 compared with control cells. Gα12, alpha 12 subunit of G protein; HUVEC, human umbilical vein endothelial 
cell; siRNA, small-interfering RNA; PI, propidium iodide.
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and apoptosis was assessed via Western blotting, using an an-
tibody to cleaved caspase-3 and a TUNEL assay to label apop-
totic cells, which were then viewed by fluorescent microscopy. 
Serum withdrawal induced apoptosis in a time-dependent 
manner. Apoptosis of HUVECs appeared within 3 h of serum 
starvation and continued until 24 h after serum starvation (Fig. 
1A and B). To investigate the role of Gα12 in serum withdraw-
al-induced apoptosis, HUVECs were transfected with Gα12 
siRNA to knock down the expression of endogenous Gα12 and 
were then serum deprived for 6 h to induce apoptosis. Down-
regulation of Gα12 expression was confirmed at both the 
mRNA and protein levels via RT-PCR and western blotting, 
respectively. As shown in Fig. 1C and D, Gα12 siRNA markedly 
increased the serum withdrawal-induced apoptosis of HU-
VECs by up to 313% when compared with control siRNA-trans-
fected cells, as shown by the level of cleaved caspase-3 expres-
sion. These data were confirmed by the TUNEL assay. The 
knockdown of Gα12 expression also augmented the serum 
withdrawal-induced p38 activation, which is known to medi-
ate the apoptosis of numerous cells, including endothelial 
cells. These results show that serum deprivation induced the 
apoptosis of HUVECs and that apoptosis was augmented by 
Gα12 deficiency in HUVECs. These findings suggest that Gα12 
might protect vascular endothelial cells from endothelial dam-
age such as apoptotic cell death. 
Gα12 siRNA augments apoptosis of HUVECs by sup-
pressing the expression of miR-155 
To investigate how Gα12 regulates serum withdrawal-induced 
apoptosis, we attempted to determine whether Gα12 is in-
volved in the regulation of miRNA expression. HUVECs were 
transfected with Gα12 siRNA, and the expression of the miR-
NAs miR-17-3, miR-31, miR-155, and miR-191, which have 
been reported to be involved in the regulation of endothelial 
damage including inflammation and apoptosis, was mea-
sured.10,11 Gα12 siRNA reduced the expression of miR-17-3, 
miR-31, and miR-191. This finding suggests that Gα12 can 
modulate the expression of miRNAs in endothelial cells. Gα12 
siRNA markedly suppressed miR-155 expression, which is 
known to be involved in the regulation of endothelial cell 
apoptosis (Fig. 2). To examine the relationship between miR-
155 and apoptosis in HUVECs, HUVECs were cultured in se-
rum-free conditions for 6 h, and the expression of miR-155 
was measured. Serum withdrawal significantly suppressed 
the expression of miR-155 (Fig. 3A). To confirm the effects of 
miR-155 on HUVEC apoptosis, HUVECs were transfected 
with an miR-155 mimic or miR-155 inhibitor, and the miR-155 
level was measured and compared with that in control-trans-
fected cells (Fig. 3B). The miR-155 mimic inhibited the serum 
withdrawal-induced apoptosis, and the miR-155 inhibitor in-
creased HUVEC apoptosis (Fig. 3C and D). These results sug-
gest that miR-155 is involved in the regulation of HUVEC apop-
tosis. To examine the role of miR-155 in the regulation of apoptosis 
in the Gα12-deficient cells, HUVECs were cotransfected with 
Gα12 siRNA and miR-155 mimic and then deprived of serum 
for 6 h. The miR-155 mimic significantly inhibited the in-
creased apoptosis and p38 phosphorylation of Gα12-deficient 
HUVECs (Fig. 3E), indicating that miR-155 acts downstream 
of Gα12 in protecting HUVECs against apoptosis. These re-
sults suggest that Gα12 modulates the apoptosis of vascular 
endothelial cells by regulating the expression of miR-155. 
DISCUSSION
In this study, we investigated the role of Gα12 in the regulation 
of vascular endothelial cell apoptosis and its underlying mech-
anisms. We found that Gα12 protected HUVECs against se-
rum withdrawal-induced apoptosis by inhibiting the suppres-
sion of miR-155 expression. This finding was supported by 
results showing that Gα12 siRNA increased the serum with-
drawal-induced apoptosis of HUVECs. Additionally, Gα12 
siRNA markedly suppressed the expression of miR-155, and 
the restoration of miR-155 by transfection with a miR-155 mim-
ic abolished the increased apoptosis of Gα12-deficient HU-
VECs. These results indicate that Gα12 can inhibit the apopto-
sis of endothelial cells by retaining the expression of miR-155 
against the cell death signal. 
As signal transducers, G proteins are involved in the modu-
lation of cellular responses, including proliferation, differenti-
ation, migration, and apoptosis. Several studies have shown 
that Gα12 is involved in the regulation of proliferation and mi-
gration. Gα12 mediates the lysophosphatidic acid-induced 
proliferation of ovarian cancer cells and simulates the expres-
sion of genes that promote cell growth in NIH3T3 cells.12,13 
Overexpression of the constitutively active mutant of Gα12 pro-
motes invasion of breast and prostate cancer cells14,15 and mi-
Fig. 2. Gα12 alters the expression of miRNAs in HUVECs. HUVECs were 
transfected with Gα12 siRNA, and the expression of miRNAs was as-
sessed via quantitative RT-PCR. The RNA was isolated, and the levels 
of miR-17-3, miR-31, miR-155, and miR-191 were measured. The histo-
grams show the average and standard deviation of three independent 
experiments. *p<0.05, **p<0.005 compared with control cells. Gα12, al-
pha 12 subunit of G protein; HUVEC, human umbilical vein endothelial 
cell; siRNA, small-interfering RNA; miRNA, microRNA; RT-PCR, real-
time PCR.
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Fig. 3. Gα12 modulates the apoptosis of HUVECs by regulating the level of miR-155. (A) Effect of serum deprivation on the expression of miR-155. HU-
VECs were deprived of serum for 6 h, and the expression of miR-155 was determined by quantitative RT-PCR. (B) Regulation of miR-155 level by a 
mimic or inhibitor of miR-155. HUVECs were transfected with a mimic or inhibitor of miR-155, and the expression of miR-155 was determined by quan-
titative RT-PCR. (C and D) Effects of a mimic and inhibitor of miR-155 on serum withdrawal-induced apoptosis. HUVECs were transfected with the 
mimic or inhibitor for miR-155 and then deprived of serum for 6 h, and the expression of cleaved caspase-3 was measured. (E) Effect of miR-155 mimic 
on apoptosis in Gα12-deficient HUVECs. HUVECs were cotransfected with Gα12 siRNA and miR-155 mimic and cultured in the serum-free condition 
for 6 h, and cleaved caspase-3 and phosphorylated p38 were assessed. The blots are representative of at least three independent experiments, and 
the histograms show the average and standard deviation. *p<0.05 compared with control cells. Gα12, alpha 12 subunit of G protein; HUVEC, human 
umbilical vein endothelial cell; RT-PCR, real-time PCR; siRNA, small-interfering RNA.
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gration of VSMCs by inducing CYR61 expression.16 Gα12 has 
also been reported to exert a proapoptotic effect in epithelial 
cells. Overexpression of the constitutively active mutant of Gα12 
stimulates the apoptosis of Madin-Darby canine kidney cells 
via c-Jun N-terminal kinase activation and also induces COS-
7 cell apoptosis via the MAPK pathway, including apoptosis-
signal regulating kinase 1 and MAPK kinase kinase 1.17,18 In 
contrast, we found that blockade of endogenous Gα12 expres-
sion augmented the serum withdrawal-induced apoptosis of 
HUVECs. This finding indicated that Gα12 inhibited the apop-
tosis of HUVECs and protected them against cellular stress-
induced endothelial dysfunction, which suggests that the role 
of Gα12 in the modulation of apoptosis might exhibit cell-type 
specificity. 
Vascular endothelial cells form the lining of the inner surface 
of blood vessels. Injury or damage to endothelial cells by in-
flammatory cytokines, oxidative stress, modified lipoproteins, 
or apoptosis initiates the pathogenesis of vascular diseases 
such as atherosclerosis. Apoptosis of endothelial cells is re-
garded as an initial step in the development of atherosclerosis. 
Apoptotic cells are found in atherosclerotic plaque and are 
thought to play a role in the formation of coronary thrombotic 
atherosclerotic plaque.19,20 Thus, apoptosis of endothelial cells 
could reflect endothelial dysfunction caused by endothelial 
damage. If so, regulating the apoptosis of endothelial cells may 
provide a way to prevent or inhibit the pathogenesis of athero-
sclerosis. Little is known about the role of Gα12 in the regula-
tion of endothelial cell death. Thus, we were interested in studying 
the role of Gα12 in the modulation of endothelial cell apoptosis. 
Our findings suggest that Gα12 plays a crucial role in the vascu-
lar system by modulating endothelial damage. 
This study also demonstrated the mechanisms by which 
Gα12 regulates the apoptosis of vascular endothelial cells. Se-
rum withdrawal caused apoptosis and the repression of miR-
155, and Gα12 siRNA markedly suppressed miR-155 expres-
sion, which caused HUVECs to become more susceptible to 
apoptosis induced by serum deprivation. Using an miR-155 
mimic, we found that increased miR-155 expression inhibited 
the serum deprivation-induced apoptosis of HUVECs and pre-
vented the increased apoptosis caused by blockade of Gα12 
expression. These findings suggest that the repression of miR-
155 is responsible for the increased susceptibility of HUVECs 
to apoptosis. Taken together, our data support the roles of 
Gα12 and miR-155 in protecting vascular endothelial cells 
from apoptotic cell death. MiR-155 has been found to be in-
volved in the development of cancer and in the pathogenesis 
of cardiovascular diseases including atherosclerosis. MiR-155 
stimulates cell proliferation and migration and inhibits apop-
tosis of renal cancer cells, which suggests that miR-155 con-
tributes to the oncogenesis of tumor cells.21 However, the role of 
miR-155 in the pathogenesis of atherosclerosis is debated. Si-
lencing miR-155 increases inflammation in macrophages and 
their lipid uptake, indicating that miR-155 is antiatherogenic. 
Another study showed that miR-155 exerts proatherogenic ef-
fects by repressing Bcl6 in macrophages.22,23 MiR-155 is en-
riched in endothelial cells, and the effects of miR-155 are 
thought to be antiatherogenic in endothelial cells, a hypothe-
sis that is supported by the finding that miR-155 inhibits an-
giotensin II (Ang II)-induced inflammation, migration, and 
apoptosis of HUVECs by targeting the Ang II type 1 recep-
tor.11,24 Consistent with this, our study showed that overexpres-
sion of miR-155 inhibited serum withdrawal-induced apopto-
sis of HUVECs and prevented the increased apoptosis mediated 
by Gα12 knockdown, indicating that miR-155 acts downstream 
of Gα12 to play a protective role against apoptotic cell death. 
Although Gα12 siRNA markedly reduced the expression of 
miR-155, Gα12 siRNA by itself did not induce detectable apop-
tosis, and miR-155 inhibition by itself could not induce apop-
tosis. The miR-155 inhibitor induced apoptosis only when HU-
VECs were exposed to an apoptotic stimulus, as shown in Fig. 
3D. This indicates that repression of miR-155 alone is not suf-
ficient to induce apoptosis, although it causes HUVECs to be-
come more susceptible to apoptosis, as shown by the increased 
apoptosis compared with HUVECs that retained the expression 
of miR-155. 
From these results, we conclude that Gα12 protects HU-
VECs against serum withdrawal-induced apoptosis by regu-
lating the expression of miR-155. This suggests that endotheli-
al apoptosis can be modulated by the Gα12 signaling pathway 
via the regulation of miRNAs. Novel strategies to protect en-
dothelial cells from endothelial dysfunction by regulating the 
Gα12 signaling pathway may have potential in preventing car-
diovascular diseases. 
ACKNOWLEDGEMENTS
This work was supported by a faculty grant from Yonsei Univer-
sity College of Medicine (No. 2014-32-0049) and a grant from 
the Korea Healthcare Technology R&D Project, Ministry for 
Health & Welfare Affairs (HI08C2149), Republic of Korea. 
REFERENCES
1. Hepler JR, Gilman AG. G proteins. Trends Biochem Sci 1992;17: 
383-7.
2. Xu N, Bradley L, Ambdukar I, Gutkind JS. A mutant alpha subunit 
of G12 potentiates the eicosanoid pathway and is highly oncogen-
ic in NIH 3T3 cells. Proc Natl Acad Sci U S A 1993;90:6741-5.
3. Gan CP, Patel V, Mikelis CM, Zain RB, Molinolo AA, Abraham MT, 
et al. Heterotrimeric G-protein alpha-12 (Gα12) subunit promotes 
oral cancer metastasis. Oncotarget 2014;5:9626-40.
4. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. 
MicroRNA expression profiles classify human cancers. Nature 2005; 
435:834-8.
5. Quintavalle M, Condorelli G, Elia L. Arterial remodeling and ath-
erosclerosis: miRNAs involvement. Vascul Pharmacol 2011;55: 
106-10.
6. Ma X, Ma C, Zheng X. MicroRNA-155 in the pathogenesis of ath-
253http://dx.doi.org/10.3349/ymj.2016.57.1.247
Hyeon Jeong Lee, et al.
erosclerosis: a conflicting role? Heart Lung Circ 2013;22:811-8.
7. Yanamadala V, Negoro H, Denker BM. Heterotrimeric G proteins 
and apoptosis: intersecting signaling pathways leading to context 
dependent phenotypes. Curr Mol Med 2009;9:527-45.
8. Seo M, Cho CH, Lee YI, Shin EY, Park D, Bae CD, et al. Cdc42-de-
pendent mediation of UV-induced p38 activation by G protein 
betagamma subunits. J Biol Chem 2004;279:17366-75.
9. Ro S, Park C, Jin J, Sanders KM, Yan W. A PCR-based method for 
detection and quantification of small RNAs. Biochem Biophys 
Res Commun 2006;351:756-63.
10. Suárez Y, Wang C, Manes TD, Pober JS. Cutting edge: TNF-in-
duced microRNAs regulate TNF-induced expression of E-selectin 
and intercellular adhesion molecule-1 on human endothelial 
cells: feedback control of inflammation. J Immunol 2010;184:21-5.
11. Liu T, Shen D, Xing S, Chen J, Yu Z, Wang J, et al. Attenuation of 
exogenous angiotensin II stress-induced damage and apoptosis 
in human vascular endothelial cells via microRNA-155 expres-
sion. Int J Mol Med 2013;31:188-96.
12. Goldsmith ZG, Ha JH, Jayaraman M, Dhanasekaran DN. Lyso-
phosphatidic Acid Stimulates the Proliferation of Ovarian Cancer 
Cells via the gep Proto-Oncogene Gα(12). Genes Cancer 2011;2: 
563-75.
13. Kumar RN, Radhika V, Audigé V, Rane SG, Dhanasekaran N. Pro-
liferation-specific genes activated by Galpha(12): a role for PDG-
FRalpha and JAK3 in Galpha(12)-mediated cell proliferation. Cell 
Biochem Biophys 2004;41:63-73.
14. Kelly P, Stemmle LN, Madden JF, Fields TA, Daaka Y, Casey PJ. A 
role for the G12 family of heterotrimeric G proteins in prostate 
cancer invasion. J Biol Chem 2006;281:26483-90.
15. Kelly P, Moeller BJ, Juneja J, Booden MA, Der CJ, Daaka Y, et al. 
The G12 family of heterotrimeric G proteins promotes breast can-
cer invasion and metastasis. Proc Natl Acad Sci U S A 2006;103: 
8173-8.
16. Kim YM, Lim SC, Han CY, Kay HY, Cho IJ, Ki SH, et al. G(alpha) 
12/13 induction of CYR61 in association with arteriosclerotic inti-
mal hyperplasia: effect of sphingosine-1-phosphate. Arterioscler 
Thromb Vasc Biol 2011;31:861-9.
17. Yanamadala V, Negoro H, Gunaratnam L, Kong T, Denker BM. 
Galpha12 stimulates apoptosis in epithelial cells through JNK1-
mediated Bcl-2 degradation and up-regulation of IkappaBalpha. 
J Biol Chem 2007;282:24352-63.
18. Berestetskaya YV, Faure MP, Ichijo H, Voyno-Yasenetskaya TA. 
Regulation of apoptosis by alpha-subunits of G12 and G13 pro-
teins via apoptosis signal-regulating kinase-1. J Biol Chem 1998; 
273:27816-23.
19. Choy JC, Granville DJ, Hunt DW, McManus BM. Endothelial cell 
apoptosis: biochemical characteristics and potential implications 
for atherosclerosis. J Mol Cell Cardiol 2001;33:1673-90.
20. Xu F, Sun Y, Chen Y, Sun Y, Li R, Liu C, et al. Endothelial cell apop-
tosis is responsible for the formation of coronary thrombotic ath-
erosclerotic plaques. Tohoku J Exp Med 2009;218:25-33.
21. Li S, Chen T, Zhong Z, Wang Y, Li Y, Zhao X. microRNA-155 silenc-
ing inhibits proliferation and migration and induces apoptosis by 
upregulating BACH1 in renal cancer cells. Mol Med Rep 2012; 
5:949-54. 
22. Huang RS, Hu GQ, Lin B, Lin ZY, Sun CC. MicroRNA-155 silenc-
ing enhances inflammatory response and lipid uptake in oxidized 
low-density lipoprotein-stimulated human THP-1 macrophages. 
J Investig Med 2010;58:961-7.
23. Nazari-Jahantigh M, Wei Y, Noels H, Akhtar S, Zhou Z, Koenen 
RR, et al. MicroRNA-155 promotes atherosclerosis by repressing 
Bcl6 in macrophages. J Clin Invest 2012;122:4190-202.
24. Zhu N, Zhang D, Chen S, Liu X, Lin L, Huang X, et al. Endothelial 
enriched microRNAs regulate angiotensin II-induced endothelial 
inflammation and migration. Atherosclerosis 2011;215:286-93.
